Why Are Patients Facing Higher Costs When They Go to the Pharmacy?
BIOtech Now Andrew Segerman BIO is out with a new whiteboard video that explores why more and more patients are facing higher […]
Category: News
Technology to Fight Malaria, Zika, and Other Mosquito-Related Diseases Is Being Blocked. Why?
BIOtech Now Josh Falzone Every year, mosquitos infect 500 million people with diseases and mosquito-borne illnesses claim nearly a million lives. Mosquito-related […]
Experts Weigh In on the Dangers of Importing Foreign Price Controls
BIOtech Now Andrew Segerman Experts recently gathered on Capitol Hill to discuss how importing foreign price controls will lead to less innovation […]
New Videos Show How “Fail First” Policies Can Fail Patients
BIOtech Now BIOtechNOW Editor Continued access to a stable treatment can make all the difference for patients with chronic illnesses like arthritis, […]
Rare Disease Drug Development Increases but Challenges Remain
BIOtech Now Andrew Segerman In a recent study published by Tufts University, researchers found that rare disease drug development is now one […]
Greenwood: A Critical Medicare Policy Has Been Delayed. Let’s Use This Opportunity to Get It Right.
BIOtech Now Andrew Segerman In a piece for Morning Consult, BIO’s Jim Greenwood writes that while CAR-T cell therapies are changing the […]
A Sustainable Movement to Curb Cancer in Africa
BIOtech Now admin In just two years, BIO Ventures for Global Health (BVGH) has made significant progress in responding to the growing […]
New BIO White Paper: Incorporating Real-World Evidence Within the Label of an FDA-Approved Drug
BIOtech Now Sesquile Ramon In today’s increasingly connected world, health care researchers have access to previously unimaginable troves of data about the […]
The DISARM Act Can Help Fix the Broken Antibiotics Market
BIOtech Now Andrew Segerman In his a recent piece for Bloomberg, reporter Robert Langreth paints a harrowing picture of the quickly deteriorating […]
AI Helps Unravel Mystery of Neurological Disorders
BIOtech Now Jeremy Isenberg Neurological disorders are estimated to affect up to 1 billion people around the world—including nearly 100 million Americans—with […]
BIO 2019 Wraps Up in Philadelphia
BIOtech Now Theresa Brady “The world is beginning to grasp that we’ve entered the dawn of a golden age of medicine. It’s […]
U.S. as a Global Leader for Patient Access
BIOtech Now BIOtechNOW Editor Some 95 percent of cancer drugs launched around the globe are available in the U.S. Given that the […]
Opioids: Changing the Paradigm of Treating Pain and Addiction—One Year Later
BIOtech Now Jeremy Isenberg Drug overdose deaths, including those involving opioids, reached 42,000 in 2016 (CDC), prompting a national response from the […]
New Approaches to Reimbursement for Gene Therapy: What Can We Learn from Models Currently in Practice?
BIOtech Now Theresa Brady It’s obvious that cost presents a major burden for patient access to gene therapy. The recent approval of […]
BIO 2019 Innovation Zone Company Snapshot: Litron Laboratories
BIOtech Now Andrew Segerman The next big medical breakthrough is on the horizon and all it takes is one idea, one vision, […]
BIO 2019 Innovation Zone Company Snapshot: HealthRhythms, Inc.
BIOtech Now Andrew Segerman The next big medical breakthrough is on the horizon and all it takes is one idea, one vision, […]
Important Perspectives on Innovation and Costs
BIOtech Now Dan Durham This is an exciting time in biomedical innovation. New and highly innovative therapies are coming to market that […]
New BIO Report on State of Innovation for Alzheimer’s Disease Therapeutics
BIOtech Now Andrew Segerman Today, BIO released a new report: The State of Innovation in Highly Prevalent Chronic Diseases Volume IV: Alzheimer’s […]
“Health care’s big spending mismatch”
BIOtech Now Andrew Segerman This week, Axios reported on new data that shows “the health care services that rack up the highest […]
New Guide to Help Consumers Navigate Genetic Health Testing
BIOtech Now Jeremy Isenberg In recent years, we have seen a growing array of direct-to-consumer (DTC) genetic testing products rise to the […]